The FDA has approved the first pill form of a fecal transplant, a procedure previously only available through a more invasive method that transferred donor stools using a colonoscope.
the treatment, called Vowst, this week. Previously, fecal transplants used only a more invasive method that transferred donor stools using a colonoscope, which is the instrument used during a colonoscopy. typically occurs in health care settings and is often related to an imbalance in the intestines after a person takes antibiotics. Symptoms include diarrhea, belly pain, and fever, but serious infections can lead to organ failure and death.
“The administration of fecal microbiota is thought to facilitate restoration of the gut flora to prevent further episodes of CDI,” the FDA explained in its approval announcement., and each time the infection recurs, the chance of another episode increases. The FDA says between 15,000 and 30,000 people die annually due toIn a study of 182 people, 12% of those who took Vowst had a recurrence during an 8-week period, compared to 40% of people who were given a placebo pill, the FDA reported.
Each capsule of Vowst contains live bacteria, which is taken from human fecal matter from screened donors. The Vowst dosing plan is four capsules taken orally once a day, for 3 days in a row. The company that makes Vowst, Seres Therapeutics, said it expects the product to be available in June.infection significantly impacts patients’ quality of life, both physically and emotionally, leaving many living in tremendous fear of future recurrences,” Christian John Lillis, executive director at the Peggy Lillis Foundation for C. diff Education and Advocacy, said in a statement.
Seres Therapeutics: “Seres Therapeutics and Nestle Health Science Announce FDA Approval of Vowst for Prevention of Recurrence of C. Difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first fecal transplant pillThe new treatment is less invasive than other transplants and uses good bacteria to prevent serious gut infections.
Read more »
First pill for fecal transplants wins FDA approvalU.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way...
Read more »
First pill for fecal transplants wins FDA approvalU.S. health officials have approved the first pill that uses healthy bacteria from human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants. The Food and Drug Administration approved the treatment Wednesday for adults who have trouble fighting off infections of an intestinal bug that causes thousands of deaths annually. The capsules from Seres Therapeutics are an easier-to-use version of a treatment some doctors have used for over a decade. It involves taking stool from healthy donors and using it to replenish healthy gut bacteria in patients at high risk for repeat infections.
Read more »
First pill for fecal transplants gains FDA approvalThe capsules from Seres Therapeutics are an easier-to-use version of a treatment some doctors have used for over a decade. Seres will co-market the treatment with Swiss food giant Nestle, which will also split the profits.
Read more »
First pill for fecal transplants wins FDA approvalU.S. health officials have approved the first pill that uses healthy bacteria from human waste to prevent dangerous gut infections — an easier way of performing so-called fecal transplants
Read more »
First pill for fecal transplants wins FDA approvalU.S. health officials have approved the first pill that uses healthy bacteria from human waste to prevent dangerous gut infections — an easier way of performing so-called fecal transplants.
Read more »